Videos

“With this study, we gained a better understanding of the features of third line therapy for overactive bladder, that patients find favorable and unfavorable,” says Anjali Kapur, MD.

Dr. Kapur on patient preferences for OAB third-line therapies

“The short-term goals are really community building [and] relationship building,” says Randy Vince Jr, MD.

Dr. Vince discusses new role in minority men’s health at University Hospitals

“I think anecdotally speaking there have been a lot of practices and states corroborating our results,” says Rutul Patel, DO, MS.

Vasectomy interest grows in states with low numbers of urologists

Samplaski is an Associate Professor of Urology and Director of the Section of Male Infertility, Andrology and Microsurgery at the Institute of Urology, University of Southern California in Los Angeles.

Treatment of azoospermia after exogenous testosterone use may require aggressive medical therapy, according to Kelli Gross, MD.

Expert Forum: Fertility after exogenous testosterone replacement

Physician Coach Support is a free resource that provides confidential, one-on-one peer support for clinicians. 

Dr. Diana Londoño on Physician Coach Support

Study authors found a rise in public interest in vasectomies, “particularly in states where abortion is or is expected to be prohibited.”

Investigators evaluate vasectomy search patterns in wake of overturning of Roe v Wade

“One of the first pieces of advice I would give is to make sure you have the OR space available for the equipment,” says Jennifer A. Linehan, MD.

Dr. Linehan’s advice for clinicians looking to incorporate HIFU into their practice

“We did not happen to find that vitamin D compared to placebo lowered the odds of having incontinence at year 2 or year 5. Nor did it lower the odds of having overactive bladder symptoms at year 5,” says Alayne Markland, DO.

Dr. Markland on vitamin D supplementation and OAB

“We really need to be thoughtful about how our treatment recommendations may induce financial toxicity in patients with advanced prostate cancer,” says Daniel D. Joyce, MD.

Dr. Joyce on financial toxicity and advanced prostate cancer treatments

“I feel like [HIFU] provided patients this intermediary treatment option…It was less invasive than radiation and surgery, but still provided cancer control, or at least for some patients delayed the time until they needed a more radical treatment,” says Jennifer A. Linehan, MD.

UTv Videos